Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Testicular germ cell cancer: recent developments in biology and clinical management

Testicular germ cell cancer: recent developments in biology and clinical management http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Andrology Wiley

Testicular germ cell cancer: recent developments in biology and clinical management

Rajpert‐De Meyts, E.
Andrology , Volume 7 (4) – Jul 1, 2019
Download PDF
3 pages

Loading next page...
 
/lp/wiley/testicular-germ-cell-cancer-recent-developments-in-biology-and-9xcycI5qic
Publisher
Wiley
Copyright
Andrology © 2019 American Society of Andrology and European Academy of Andrology
ISSN
2047-2919
eISSN
2047-2927
DOI
10.1111/andr.12675
Publisher site
See Article on Publisher Site

Abstract

Journal

Andrology – Wiley

Published: Jul 1, 2019

References

  • Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine
    Albany, C; Hever‐Jardine, MP; Herrmann, KM; Yim, CY; Tam, J; Warzecha, JM; Shin, L; Bock, SE; Curran, BS; Chaudhry, AS; Kim, F; Sandusky, GE; Taverna, P; Freemantle, SJ; Christensen, BC; Einhorn, LH; Spinella, MJ
  • Germ cell neoplasia in situ (GCNIS): evolution of the current nomenclature for testicular pre‐invasive germ cell malignancy
    Berney, DM; Looijenga, LHJ; Idrees, MT; Oosterhuis, JW; Rajpert‐De Meyts, E; Ulbright, TM; Skakkebæk, NE
  • Germline genome protection: implications for gamete quality and germ cell tumorigenesis
    Bloom, JC; Loehr, AR; Schimenti, JC; Weiss, RS
  • Cellular origin of microRNA‐371a‐3p in healthy males based on systematic urogenital tract tissue evaluation
    Boellaard, WPA; Gillis, AJM; Leenders, GJLH; Stoop, H; Agthoven, T; Dorssers, LCJ; Dinkelman‐Smit, M; Boormans, JL; Looijenga, LHJ
  • Hypogonadism in testicular cancer patients is associated with risk factors of cardiovascular disease and the metabolic syndrome
    Bogefors, C; Isaksson, S; Bobjer, J; Kitlinski, M; Leijonhufvud, I; Link, K; Giwercman, A
  • Trend analysis and regional tumor incidence in Germany for testicular cancer between 2003 and 2014
    Brandt, MP; Gust, KM; Bon, D; Tsaur, I; Thomas, C; Neisius, A; Haferkamp, E; Herrmann, E; Bartsch, G
  • Immune mechanisms and possible immune therapy in testicular germ cell tumours
    Chovanec, M; Mardiak, J; Mego, M
  • Functions of genes related to testicular germ cell tumour development
    Das, MK; Kleppa, L; Haugen, TB
  • Meiotic gene activation in somatic and germ cell tumours
    Feichtinger, J; McFarlane, RJ
  • Targeted serum miRNA (TSmiR) test for diagnosis and follow‐up of (testicular) germ cell cancer patients: a proof of principle
    Gillis, AJ; Rijlaarsdam, MA; Eini, R; Dorssers, LC; Biermann, K; Murray, MJ; Nicholson, JC; Coleman, N; Dieckmann, KP; Belge, G; Bullerdiek, J; Xu, T; Bernard, N; Looijenga, LH
  • The puzzling incidence of testicular cancer in New Zealand: what can we learn?
    Gurney, JK
  • Immunolocalization of DMRTB1 in human testis with normal and impaired spermatogenesis
    Hilbold, E; Bergmann, M; Fietz, D; Kliesch, S; Weidner, W; Langeheine, M; Rode, K; Brehm, R
  • Dysregulation of the mitosis‐meiosis switch in testicular carcinoma in situ
    Jørgensen, A; Nielsen, JE; Almstrup, K; Toft, BG; Petersen, BL; Rajpert‐De, Meyts E
  • New insights into germ cell tumor genomics
    Lafin, JT; Bagrodia, A; Woldu, S; Amatruda, JF
  • Runs of homozygosity and testicular cancer risk
    Loveday, C; Sut, A; Litchfield, K; Levy, M; Holroyd, A; Broderick, P
  • Epigenetic treatment combinations to effectively target cisplatin‐resistant germ cell tumors ‐past, present, and future considerations
    Oing, C; Skowron, MA; Bokemeyer, C; Nettersheim, D
  • A quantitative global proteomics approach to understanding the functional pathways dysregulated in the spermatozoa of asthenozoospermic testicular cancer patients
    Panner Selvam, MK; Agarwal, A; Pushparaj, PN
  • Expression of microRNA‐371a‐3p in seminal plasma and ejaculate is associated with sperm concentration
    Radtke, A; Dieckmann, KP; Grobelny, F; Salzbrunn, A; Oing, C; Schulze, W; Belge, G
  • Increasing international efforts to understand and conquer testicular germ cell cancer
    Rajpert‐De Meyts, E; Daugaard, G; Almstrup, K; Jørgensen, A; Rørth, M; Jørgensen, N; Maase, H; Skakkebaek, NE
  • Integrated molecular characterization of testicular germ cell tumors
    Shen, H; Shih, J; Hollern, DP; Wang, L; Bowlby, R; Tickoo, SK; Hoadley, KA
  • Carcinoma in situ of the testis: frequency and relationship to invasive germ cell tumours in infertile men
    Skakkebaek, NE
  • Association between testicular dysgenesis syndrome (TDS) and testicular neoplasia: evidence from 20 adult patients with signs of maldevelopment of the testis
    Skakkebaek, NE; Holm, M; Hoei‐Hansen, C; Jørgensen, N; Rajpert‐De, Meyts E
  • Longitudinal serum testosterone, luteinizing hormone, and follicle‐stimulating hormone levels in a population‐based sample of long‐term testicular cancer survivors
    Sprauten, M; Brydøy, M; Haugnes, HS; Cvancarova, M; Bjøro, T; Bjerner, J; Fosså, SD; Oldenburg, J
  • Insulin‐like factor 3, luteinizing hormone and testosterone in testicular cancer patients: effects of β‐hCG and cancer treatment
    Steggink, LC; Beek, AP; Boer, H; Meijer, C; Lubberts, S; Oosting, SF; Jong, IJ; Ginkel, RJ; Lefrandt, JD; Gietema, JA; Nuver, J
  • Quantification of the Leydig cell compartment in testicular biopsies and association with biochemical Leydig cell dysfunction in testicular cancer survivors
    Tarsitano, MG; Bandak, M; Jørgensen, N; Skakkebaek, NE; Juul, A; Lenzi, A; Daugaard, G; Rajpert‐De, Meyts E
  • Genomic evolution and chemoresistance in germ‐cell tumours
    Taylor‐Weiner, A; Zack, T; O'Donnell, E; Guerriero, JL; Bernard, B; Reddy, A; Han, GC; AlDubayan, S; Amin‐Mansour, A; Schumacher, SE; Litchfield, K; Turnbull, C; Gabriel, S; Beroukhim, R; Getz, G; Carter, SL; Hirsch, MS; Letai, A; Sweeney, C; Allen, EM
  • International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973–2007
    Trabert, B; Chen, J; Devesa, SS; Bray, F; McGlynn, KA
  • Genitourinary cancer patients have worse baseline semen parameters than healthy sperm bankers
    Xu, R; Centola, GM; Tanrikut, C